{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:21:22Z","timestamp":1790270482435,"version":"4.1.0"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2014,3,14]],"date-time":"2014-03-14T00:00:00Z","timestamp":1394755200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0090463","type":"journal-article","created":{"date-parts":[[2014,3,14]],"date-time":"2014-03-14T16:19:58Z","timestamp":1394813998000},"page":"e90463","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":29,"title":["CCR2 Gene Deletion and Pharmacologic Blockade Ameliorate a Severe Murine Experimental Autoimmune Neuritis Model of Guillain-Barr\u00e9 Syndrome"],"prefix":"10.1371","volume":"9","author":[{"given":"Furong","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nejla","family":"Yosef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetan","family":"Lakshmana Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ailing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon C.","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafiza Rahman","family":"Tithi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eroboghene E.","family":"Ubogu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,3,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/00019052-200210000-00008","article-title":"Acute immunoinflammatory neuropathy: update on Guillain-Barr\u00e9 syndrome","volume":"15","author":"H Hartung","year":"2002","journal-title":"Curr Opin Neurol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","article-title":"Guillain-Barr\u00e9 syndrome","volume":"366","author":"R Hughes","year":"2005","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/mus.23829","article-title":"The role of chemokines in Guillain-Barre syndrome","volume":"48","author":"S Chiang","year":"2013","journal-title":"Muscle Nerve"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00415-010-5836-5","article-title":"The role of cytokines in Guillain-Barre syndrome","volume":"258","author":"MO Lu","year":"2011","journal-title":"J Neurol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0165-5728(02)00393-4","article-title":"Monocyte chemoattractant protein 1 and chemokine receptor CCR2 productions in Guillain-Barr\u00e9 syndrome and experimental autoimmune neuritis","volume":"134","author":"D Orlikowski","year":"2003","journal-title":"J Neuroimmunol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1023\/A:1024532715775","article-title":"Aberrated levels of cerebrospinal fluid chemokines in Guillain-Barr\u00e9 syndrome and chronic inflammatory demyelinating polyradiculoneuropathy","volume":"23","author":"R Press","year":"2003","journal-title":"J Clin Immunol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/ncpneuro0452","article-title":"From bench to bedside\u2014experimental rationale for immune-specific therapies in the inflamed peripheral nerve","volume":"3","author":"G Meyer zu H\u00f6rste","year":"2007","journal-title":"Nat Clin Pract Neurol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-5728(00)00249-6","article-title":"Experimental allergic neuritis in the SJL\/J mouse: induction of severe and reproducible disease with bovine peripheral nerve myelin and pertussis toxin with or without interleukin-12","volume":"107","author":"D Calida","year":"2000","journal-title":"J Neuroimmunol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jneuroim.2009.11.019","article-title":"Clinical, electrophysiological and pathologic correlations in a severe murine experimental autoimmune neuritis model of Guillain-Barr\u00e9 syndrome","volume":"219","author":"R Xia","year":"2010","journal-title":"J Neuroimmunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-1-62703-426-5_2","article-title":"Chemokine-dependent signaling pathways in the peripheral nervous system","volume":"1013","author":"EE Ubogu","year":"2013","journal-title":"Methods Mol Biol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/brain\/awh655","article-title":"Modulating CCR2 and CCL2 at the blood-brain barrier: relevance for multiple sclerosis pathogenesis","volume":"129","author":"D Mahad","year":"2006","journal-title":"Brain"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0301-0082(00)00060-5","article-title":"The role of macrophages in immune-mediated damage to the peripheral nervous system","volume":"64","author":"R Kiefer","year":"2001","journal-title":"Prog Neurobiol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1365-2990.2010.01092.x","article-title":"Selective expression and cellular localization of pro-inflammatory chemokine ligand\/receptor pairs in the sciatic nerves of a severe murine experimental autoimmune neuritis model of Guillain-Barr\u00e9 syndrome","volume":"36","author":"RH Xia","year":"2010","journal-title":"Neuropathol Appl Neurobiol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/vim.2006.0068","article-title":"CCR2 regulates development of Theiler's murine encephalomyelitis virus-induced demyelinating disease","volume":"20","author":"JL Bennett","year":"2007","journal-title":"Viral Immunol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1172\/JCI119798","article-title":"Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice","volume":"100","author":"L Boring","year":"1997","journal-title":"J Clin Invest"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.intimp.2012.11.016","article-title":"Optimized dosing of a CCR2 antagonist for amplification of vaccine immunity","volume":"15","author":"LA Mitchell","year":"2013","journal-title":"Int Immunopharmacol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/mus.21588","article-title":"Dorsal caudal tail and sciatic motor nerve conduction studies in adult mice: technical aspects and normative data","volume":"41","author":"R Xia","year":"2010","journal-title":"Muscle Nerve"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1529-8027.2012.00375.x","article-title":"Behavioral, electrophysiological, and histopathological characterization of a severe murine chronic demyelinating polyneuritis model","volume":"17","author":"EE Ubogu","year":"2012","journal-title":"J Peripher Nerv Syst"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1523\/JNEUROSCI.07-10-03362.1987","article-title":"Axonal signals regulate the differentiation of non-myelin-forming Schwann cells: an immunohistochemical study of galactocerebroside in transected and regenerating nerves","volume":"7","author":"KR Jessen","year":"1987","journal-title":"J Neurosci"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Kruisbeek AM (2001) Isolation of mouse mononuclear cells. Curr Protoc Immunol Chapter 3: Unit 3 1.","DOI":"10.1002\/0471142735.im0301s39"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/NEN.0b013e3181c84a9a","article-title":"Development and characterization of a novel human in vitro blood-nerve barrier model using primary endoneurial endothelial cells","volume":"69","author":"N Yosef","year":"2010","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s10571-013-9946-3","article-title":"VEGF-A165 potently induces human blood-nerve barrier endothelial cell proliferation, angiogenesis, and wound healing in vitro","volume":"33","author":"CL Reddy","year":"2013","journal-title":"Cell Mol Neurobiol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.mvr.2012.01.005","article-title":"GDNF restores human blood-nerve barrier function via RET tyrosine kinase-mediated cytoskeletal reorganization","volume":"83","author":"N Yosef","year":"2012","journal-title":"Microvasc Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1002\/jcp.24100","article-title":"alpha(M)beta(2)-integrin-intercellular adhesion molecule-1 interactions drive the flow-dependent trafficking of Guillain-Barre syndrome patient derived mononuclear leukocytes at the blood-nerve barrier in vitro","volume":"227","author":"N Yosef","year":"2012","journal-title":"J Cell Physiol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10571-012-9882-7","article-title":"An immortalized human blood-nerve barrier endothelial cell line for in vitro permeability studies","volume":"33","author":"N Yosef","year":"2013","journal-title":"Cell Mol Neurobiol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1021\/tx6003453","article-title":"Peripheral nerve protein expression and carbonyl content in N,N-diethlydithiocarbamate myelinopathy","volume":"20","author":"OM Viquez","year":"2007","journal-title":"Chem Res Toxicol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/glia.21041","article-title":"Toll-like receptor expression in the peripheral nerve","volume":"58","author":"S Goethals","year":"2010","journal-title":"Glia"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/jir.2008.0027","article-title":"Monocyte chemoattractant protein-1 (MCP-1): an overview","volume":"29","author":"S Deshmane","year":"2009","journal-title":"J Interferon Cytokine Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1124\/mol.110.068486","article-title":"Different effects of the different natural CC chemokine receptor 2b ligands on beta-arrestin recruitment, Galphai signaling, and receptor internalization","volume":"79","author":"YA Berchiche","year":"2011","journal-title":"Mol Pharmacol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"e37208","DOI":"10.1371\/journal.pone.0037208","article-title":"CCR2 acts as scavenger for CCL2 during monocyte chemotaxis","volume":"7","author":"S Volpe","year":"2012","journal-title":"PLoS One"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"31509","DOI":"10.1074\/jbc.M110.124891","article-title":"The C terminus of mouse monocyte chemoattractant protein 1 (MCP1) mediates MCP1 dimerization while blocking its chemotactic potency","volume":"285","author":"Y Yao","year":"2010","journal-title":"J Biol Chem"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0165-5728(00)00343-X","article-title":"The chemokine receptor CCR2 is involved in macrophage recruitment to the injured peripheral nervous system","volume":"110","author":"H Siebert","year":"2000","journal-title":"J Neuroimmunol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/nn.2887","article-title":"Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool","volume":"14","author":"B Ajami","year":"2011","journal-title":"Nat Neurosci"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.nbd.2013.03.005","article-title":"The neuroinflammatory role of Schwann cells in disease","volume":"55","author":"E Ydens","year":"2013","journal-title":"Neurobiol Dis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/mus.20893","article-title":"The immunocompetence of Schwann cells","volume":"37","author":"G Meyer zu H\u00f6rste","year":"2008","journal-title":"Muscle Nerve"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.nbd.2004.04.007","article-title":"CCR5 deficiency does not prevent P0 peptide 180-199 immunized mice from experimental autoimmune neuritis","volume":"16","author":"R Duan","year":"2004","journal-title":"Neurobiol Dis"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2174\/187153011795564124","article-title":"Chemokine receptors as specific anti-inflammatory targets in peripheral nerves","volume":"11","author":"EE Ubogu","year":"2011","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/brain\/awf070","article-title":"Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10","volume":"125","author":"B Kieseier","year":"2002","journal-title":"Brain"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1749-6632.2009.04813.x","article-title":"CXCR3, inflammation, and autoimmune diseases","volume":"1173","author":"S Lacotte","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMra052723","article-title":"The many roles of chemokines and chemokine receptors in inflammation","volume":"354","author":"I Charo","year":"2006","journal-title":"N Engl J Med"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.immuni.2012.05.008","article-title":"The chemokine superfamily revisited","volume":"36","author":"A Zlotnik","year":"2012","journal-title":"Immunity"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0090463","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T09:23:38Z","timestamp":1565256218000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0090463"}},"subtitle":[],"editor":[{"given":"Thomas H.","family":"Gillingwater","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,3,14]]},"references-count":41,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,3,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0090463","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,14]]}}}